FOLLOWUS
Casticin Attenuates Stemness in Cervical Cancer Stem-Like Cells by Regulating Activity and Expression of DNMT1
- Chinese Journal of Integrative Medicine Vol. 29, Issue 3, Pages: 224-232(2023)
- Affiliations：
1.Medical College, Hunan University of Medicine, Huaihua, Hunan Province (418000), China
2.Clinical Department of Guangdong Metabolic Disease Research Centre of Integrated Chinese and Western Medicine, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou (510062), China
3.Institute of Chemical Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou (510530), China
4.The Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Medical College, Hunan Normal University, Changsha (410013), China
5.The Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha (410013), China
- Author bio：
Prof. REN Kai-qun, E-mail: kaiqunren@126.com
- Funds：
DOI：10.1007/s11655-022-3469-z
CLC：Published：2023-03，
Published Online：09 July 2022，
Accepted：21 December 2021
Scan for full text
WANG Xue-li, CAO Xiao-zheng, WANG Dao-yuan, et al. Casticin Attenuates Stemness in Cervical Cancer Stem-Like Cells by Regulating Activity and Expression of DNMT1. [J]. Chinese Journal of Integrative Medicine 29(3):224-232(2023)
WANG Xue-li, CAO Xiao-zheng, WANG Dao-yuan, et al. Casticin Attenuates Stemness in Cervical Cancer Stem-Like Cells by Regulating Activity and Expression of DNMT1. [J]. Chinese Journal of Integrative Medicine 29(3):224-232(2023) DOI： 10.1007/s11655-022-3469-z.
摘要
目的:
2
本研究旨在评估白花蛇舌草总黄酮 (Flavonoids of Oldenlandia diffusa
FOD) 对人胃癌细胞凋亡的诱导作用及其对胃癌细胞周期的影响
探讨FOD与控制活性氧 (Reactive Oxygen Species
ROS) 产生的线粒体凋亡途径相关的作用机制
并探讨FOD对小鼠异种移植模型的影响
以期为临床胃癌防治提供实验依据.
方法:
2
酶法-超声分离提取及D-101树脂纯化FOD后
利用HPLC对其潜在的生物活性成分进行表征. 不同浓度FOD (64
96
128
160 μg/mL) 处理MKN-45、AGS及GES-1细胞
采用MTT评价药物对细胞活力的影响
Hoechst 33342染色技术用于观察细胞核形态变化
流式细胞术检测细胞凋亡率及细胞周期变化
激光共聚焦显微镜检测胃癌细胞内ROS的产生
荧光显微镜观察肿瘤细胞线粒体膜电位 (Mitochondrial Membrane Potential
MMP) 变化
免疫印迹检测细胞周期蛋白及线粒体途径相关凋亡蛋白表达. 建立MKN-45细胞小鼠异种移植模型
瘤组织经HE染色后确定造模成功
不同剂量FOD (50
100
200 mg/kg/d) 灌胃干预后
测量瘤体积及瘤重
免疫组化检测增殖标志物PCNA及Ki-67表达水平
ELISA检测肿瘤标志物CA72-4表达水平.
结果:
2
FOD对MKN-45及AGS增殖有明显抑制作用
使细胞周期阻滞在G1/S期
FOD诱导胃癌细胞凋亡过程中ROS积累
进而引起MMP改变
Cyclin A、Cdk2、Bcl-2、Pro-Caspase-9、Cytochrome C蛋白表达水平以剂量依赖性下降
Apaf-1、Cleaved-Caspase-3、Bax表达水平以剂量依赖性增加 (
P
<
0.05) . FOD抑制MKN-45荷瘤小鼠肿瘤生长
FOD各剂量组瘤组织中PCNA、Ki-67的表达水平与模型对照组相比降低
血清肿瘤标志物CA72–4表达水平较模型对照组降低 (
P
<
0.05) .
结论:
2
FOD通过激活线粒体控制的内在途径抑制人胃癌细胞的增殖并诱导其凋亡.
Abstract
Objective:
2
To explore whether casticin (CAS) suppresses stemness in cancer stem-like cells (CSLCs) obtained from human cervical cancer (CCSLCs) and the underlying mechanism.
Methods:
2
Spheres from HeLa and CaSki cells were used as CCSLCs. DNA methyltransferase 1 (DNMT1) activity and mRNA levels
self-renewal capability (Nanog and Sox2)
and cancer stem cell markers (CD133 and CD44) were detected by a colorimetric DNMT activity/inhibition assay kit
quantitative real-time reverse transcription-polymerase chain reaction
sphere and colony formation assays
and immunoblot
respectively. Knockdown and overexpression of DNMT1 by transfection with shRNA and cDNA
respectively
were performed to explore the mechanism for action of CAS (0
10
30
and 100 nmol/L).
Results:
2
DNMT1 activity was increased in CCSLCs compared with HeLa and CaSki cells (
P
<
0.05). In addition
HeLa-derived CCSLCs transfected with DNMT1 shRNA showed reduced sphere and colony formation abilities
and lower CD133
CD44
Nanog and Sox2 protein expressions (
P
<
0.05). Conversely
overexpression of DNMT1 in HeLa cells exhibited the oppositive effects. Furthermore
CAS significantly reduced DNMT1 activity and transcription levels as well as stemness in HeLa-derived CCSLCs (
P
<
0.05). Interestingly
DNMT1 knockdown enhanced the inhibitory effect of CAS on stemness. As expected
DNMT1 overexpression reversed the inhibitory effect of CAS on stemness in HeLa cells.
Conclusion:
2
CAS effectively inhibits stemness in CCSLCs through suppression of DNMT1 activation
suggesting that CAS acts as a promising preventive and therapeutic candidate in cervical cancer.
关键词
中药白花蛇舌草黄酮癌症凋亡线粒体
Keywords
cervical cancercancer stem cellcasticinDNA methyltransferase 1therapeutic action
references
Knaul FM, Rodriguez NM, Arreola-Ornelas H, Olson JR. Cervical cancer: lessons learned from neglected tropical diseases. Lancet Glob Health 2019;7:e299-e300.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30.
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8:e191-e203.
Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer 2013;13:727-738.
Organista-Nava J, Gómez-Gómez Y, Garibay-Cerdenares OL, Leyva-Vázquez MA, Illades-Aguiar B. Cervical cancer stem cell-associated genes: prognostic implications in cervical cancer. Oncol Lett 2019;18:7-14.
Strauss J, Figg WD. Epigenetic approaches to overcoming chemotherapy resistance. Lancet Oncol 2015;16:1013-1015.
Pathania R, Ramachandran S, Elangovan S, Padia R, Yang P, Cinghu S, et al. DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis. Nat Commun 2015;6:6910.
Trowbridge JJ, Sinha AU, Zhu N, Li M, Armstrong SA, Orkin SH. Haploinsufficiency of DNMT1 impairs leukemia stem cell function through derepression of bivalent chromatin domains. Genes Dev 2012;26:344-349.
Shafabakhsh R, Asemi Z. Quercetin: a natural compound for ovarian cancer treatment. J Ovarian Res 2019;12:55.
Maiuthed A, Chantarawong W, Chanvorachote P. Lung cancer stem cells and cancer stem cell-targeting natural compounds. Anticancer Res 2018;38:3797-3809.
Kim C, Kim B. Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: a review. Nutrients 2018;10:1021.
Cheng ZY, Hsiao YT, Huang YP, Peng SF, Huang WW, Liu KC, et al. Casticin induces DNA damage and affects DNA repair associated protein expression in human lung cancer A549 cells. Molecules 2020;25:341.
He G, Cao X, He M, Sheng X, Wu Y, Ai X. Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line. Oncol Lett 2014;7:2023-2028.
Liu F, Cao X, Liu Z, Guo H, Ren K, Quan M, et al. Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt. Acta Biochim Biophys Sin 2014;46:15-21.
He M, Cao XC, He GC, Sheng XF, Ai XH, Wu YH. Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through downregulating Twist. Oncol Lett 2014;7:1625-1631.
Cao X, Zou H, Cao J, Cui Y, Sun S, Ren K, et al. A candidate Chinese medicine preparation-Fructus Viticis total flavonoids inhibits stem-like characteristics of lung cancer stem-like cells. BMC Complement Altern Med 2016;16:364.
Yang F, He K, Huang L, Zhang L, Liu A, Zhang J. Casticin inhibits the activity of transcription factor Sp1 and the methylation of RECK in MGC803 gastric cancer cells. Exp Ther Med 2017;13:745-750.
Li X, Wang L, Cao X, Zhou L, Xu C, Cui Y, et al. Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p. Toxicol Appl Pharmacol 2020;396:114998.
Liu J, Cao XC, Xiao Q, Quan MF. Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α. Mol Med Rep 2015;11:665-669.
Wang L, Liu Y, Zhou Y, Wang J, Tu L, Sun Z, et al. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways. J Exp Clin Cancer Res 2019;38:93.
Cao X, Liu L, Cao X, Cui Y, Zou C, Chen A, et al. The DNMT1/miR-34a/FOXM1 axis contributes to stemness of liver cancer cells. J Oncol 2020;2020:8978930.
She S, Zhao Y, Kang B, Chen C, Chen X, Zhang X, et al. Combined inhibition of JAK1/2 and DNMT1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells. Cell Death Dis 2020;11:724.
Piyathilake CJ, Badiga S, Borak SG, Weragoda J, Bae S, Matthews R, et al. A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 2017;9:413-420.
Jiang H, Cao HJ, Ma N, Bao WD, Wang JJ, Chen TW, et al. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis. Proc Natl Acad Sci U S A 2020;117:4770-4780.
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estima tes of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8:e191-e203.
Mancarella D, Plass C. Epigenetic signatures in cancer:proper controls, current challenges and the potential for clinical translation. Genome Med 2021;13:23.
Li T, Wang L, Du Y, Xie S, Yang X, Lian F, et al. Structural and mechanistic insights into UHRF1-mediated DNMT1 activation in the maintenance DNA methylation. Nucleic Acids Res 2018;46:3218-3231.
Nishiyama A, Mulholland CB, Bultmann S, Kori S, Endo A, Saeki Y, et al. Two distinct modes of DNMT1 recruitment ensure stable maintenance DNA methylation. Nat Commun 2020;11:1222.
Chen YZ, Wang JW, Meng FC, Yang P, Zhang XG, Wu HZ. LncRNATCF7 up-regulates DNMT1 mediated by HPV-18 E6 and regulates biological behavior of cervical cancer cells by inhibiting miR-155. Eur Rev Med Pharmacol Sci 2019;23:8779-8787.
Li L, Wang S. DNA methyltransferase (DNMTs) expression in cervical cancer tissues and its relationship with HPV infection and tumor malignancy. J Hainan Med Univ (Chin) 2017;23:136-139.
Faghihloo E, sadeghiZadeh M, shahmahmoodi S, moKhTari-aZad T. Transcriptional suppression of E-cadherin by HPV-16 E6 and E7 oncogenes is independent of hypermethylation of E-cadherin promoter. Iran Red Crescent Med 2017;19:e30434.
Liu H, Song Y, Qiu H, Liu Y, Luo K, Yi Y, et al. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. Cell Death Differ 2020;27:966-983.
Zagorac S, Alcala S, Fernandez Bayon G, Bou Kheir T, Schoenhals M, González-Neira A, et al. DNMT1 inhibition reprograms pancreatic cancer stem cells via upregulation of the mir-17-92 cluster. Cancer Res 2016;76:4546-4558.
Liu CC, Lin JH, Hsu TW, Su K, Li AF, Hsu HS, et al. IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation. Int J Cancer 2015;136:547-559.
Rasul A, Zhao BJ, Liu J, Liu B, Sun JX, Li J, et al. Molecular mechanisms of casticin action: an update on its antitumor functions. Asian Pac J Cancer Prev 2014;15:9049-9058.
Lee JG, Yon JM, Lin C, Jung AY, Jung KY, Nam SY. Combined treatment with capsaicin and resveratrol enhances neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons. Food Chem Toxicol 2012;50:3877-3785.
Chan EWC, Wong SK, Chan HT. Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties. J Integr Med 2018;16:147-152.
0
Views
2
Downloads
0
CSCD
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
- Tel：010-62886827, 62877592 Fax：010-62874291
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
